ES1302246U - Hemostatic cast (Machine-translation by Google Translate, not legally binding) - Google Patents
Hemostatic cast (Machine-translation by Google Translate, not legally binding) Download PDFInfo
- Publication number
- ES1302246U ES1302246U ES202330143U ES202330143U ES1302246U ES 1302246 U ES1302246 U ES 1302246U ES 202330143 U ES202330143 U ES 202330143U ES 202330143 U ES202330143 U ES 202330143U ES 1302246 U ES1302246 U ES 1302246U
- Authority
- ES
- Spain
- Prior art keywords
- mold
- translation
- machine
- cast
- legally binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
DESCRIPCIÓNDESCRIPTION
Molde HemostáticoHemostatic Mold
SECTOR DE LA TÉCNICATECHNIQUE SECTOR
La presente invención se refiere al campo de la medicina.The present invention relates to the field of medicine.
En particular, la presente invención se refiere a un molde, ideado para la hemostasia de heridas después de la extirpación de un tumor sólido, preferiblemente después de una nefrectomía parcial.In particular, the present invention relates to a cast, intended for wound haemostasis after removal of a solid tumor, preferably after partial nephrectomy.
ANTECEDENTES DE LA INVENCIÓNBACKGROUND OF THE INVENTION
La mayoría de las veces, para tratar el cáncer de riñón o para extirpar un tumor no canceroso (tumor benigno) se realiza una nefrectomía. En algunos casos, se realizan nefrectomías para tratar pacientes enfermos o pacientes con una lesión grave de riñón. En el caso de una nefrectomía de donación, el cirujano urólogo extrae un riñón sano de un donante para trasplantarlo a una persona que necesita un riñón funcional.Most of the time, to treat kidney cancer or to remove a non-cancerous growth (benign growth), a nephrectomy is done. In some cases, nephrectomies are performed to treat sick patients or patients with severe kidney injury. In the case of a donor nephrectomy, the urological surgeon removes a healthy kidney from a donor to transplant it into a person who needs a functioning kidney.
El cirujano puede realizar una nefrectomía a través de una sola incisión en el abdomen o lateral (nefrectomía abierta) o a través de una serie de pequeñas incisiones en el abdomen usando una cámara (nefrectomía laparoscópica).The surgeon may perform a nephrectomy through a single incision in the abdomen or side (open nephrectomy) or through a series of small incisions in the abdomen using a camera (laparoscopic nephrectomy).
En algunos casos, estos procedimientos laparoscópicos se realizan mediante un sistema robótico de cirugía, donde el cirujano controla el brazo de la cámara y los brazos mecánicos con los instrumentos quirúrgicos pertinentes.In some cases, these laparoscopic procedures are performed using a robotic surgical system, where the surgeon controls the camera arm and mechanical arms with the appropriate surgical instruments.
Cuando se realiza una nefrectomía, se extrae todo o parte del riñón. En una nefrectomía total, el cirujano extirpa todo el riñón y, a menudo, algunas estructuras más, como parte del tubo que conecta el riñón con la vejiga (uréter), u otras estructuras adyacentes como la glándula suprarrenal o los ganglios linfáticos. Por el contrario, en las nefrectomías parciales, el cirujano extirpa el tejido enfermo del riñón y deja el tejido sano en su lugar.When a nephrectomy is performed, all or part of the kidney is removed. In a total nephrectomy, the surgeon removes the entire kidney and often a few other structures, such as part of the tube that connects the kidney to the bladder (ureter), or other nearby structures such as the adrenal gland or lymph nodes. In contrast, in partial nephrectomies, the surgeon removes diseased kidney tissue and leaves healthy tissue in its place.
Particularmente, en una nefrectomía parcial, el cirujano extirpa la parte del riñón que contiene el tumor o la lesión. Una vez extirpado el tumor, se necesita reparar la sutura provocada (renorrafia), lo que conduce a un daño tisular asociado, entre otros efectos secundarios. En particular, el uso de renorrafia se asocia con el daño del parénquima sano que provoca un deterioro de la función renal, riesgo de complicaciones como la fístula arteriocaliceal, y un posible aumento del tiempo de isquemia.In particular, in a partial nephrectomy, the surgeon removes the part of the kidney that contains the tumor or lesion. Once the tumor is removed, the provoked suture needs to be repaired (renorrhaphy), which leads to associated tissue damage, among other side effects. In particular, the use of renorrhaphy is associated with damage to healthy parenchyma leading to impaired renal function, risk of complications such as arteriocalyceal fistula, and a possible increase in ischemia time.
Por lo tanto, existe una necesidad médica no satisfecha de encontrar estrategias para evitar los efectos secundarios causados por la renorrafia tras una nefrectomía parcial después de la extirpación de un tumor sólido, por ejemplo.Therefore, there is an unmet medical need to find strategies to avoid the side effects caused by renorrhaphy after partial nephrectomy after removal of a solid tumor, for example.
La presente invención está enfocada a solucionar este problema. Se propone una nueva estrategia para la hemostasia de las heridas ocurridas después de una nefrectomía en la extirpación de un tumor sólido. Esta estrategia innovadora evita la necesidad de suturas después de la cirugía, eliminando los efectos secundarios observados cuando se realizan suturas y permitiendo la aplicación eficaz de compuestos hemostáticos.The present invention is focused on solving this problem. A new strategy for hemostasis of wounds after nephrectomy in the removal of a solid tumor is proposed. This innovative approach avoids the need for sutures after surgery, eliminating the side effects seen when suturing is done and allowing effective application of hemostatic compounds.
EXPLICACIÓN DE LA INVENCIÓNEXPLANATION OF THE INVENTION
La presente invención se refiere a un molde para la hemostasia de heridas después de la extirpación de un tumor sólido, preferiblemente después de una nefrectomía parcial. El molde de la invención permite una hemostasia precisa y eficaz, prescindiendo de otras formas de hemostasia como la sutura.The present invention relates to a cast for hemostasis of wounds after removal of a solid tumor, preferably after partial nephrectomy. The mold of the invention allows a precise and effective haemostasis, dispensing with other forms of haemostasis such as suturing.
El molde de la invención comprende i) una zona externa, en contacto con la superficie donde se produce la hemostasia; y ii) un componente comprimible y/o moldeable que se colocaría dentro del molde, llenando todo el volumen de este.The mold of the invention comprises i) an external zone, in contact with the surface where hemostasis occurs; and ii) a compressible and/or moldable component that would be placed inside the mold, filling its entire volume.
Así, la presente invención se refiere a un molde diseñado para la hemostasia de heridas tras la extirpación de un tumor sólido, caracterizado por estar constituido por:Thus, the present invention refers to a mold designed for hemostasis of wounds after removal of a solid tumor, characterized by being made up of:
a) Una superficie externa (1) que queda en contacto con la herida;a) An external surface (1) that remains in contact with the wound;
b) Un componente comprimible y/o moldeable (2) que se coloca en el interior del molde, llenando todo su volumen; yb) A compressible and/or moldable component (2) that is placed inside the mold, filling its entire volume; and
c) Un mango (3) formado por el componente (2). c) A handle (3) formed by the component (2).
BREVE DESCRIPCIÓN DE LOS DIBUJOSBRIEF DESCRIPTION OF THE DRAWINGS
Figura 1. Se ilustra el molde de la invención mostrando la superficie externa (1) que queda en contacto con la herida.Figure 1. The mold of the invention is illustrated showing the external surface (1) that remains in contact with the wound.
Figura 2. Se ilustra el molde de la invención mostrando la superficie externa (1), el componente compresible y/o moldeable (2) que se coloca dentro del molde, llenando todo su volumen y el mango (3) formado por el componente (2).Figure 2. The mold of the invention is illustrated showing the external surface (1), the compressible and/or moldable component (2) that is placed inside the mold, filling its entire volume, and the handle (3) formed by the component ( 2).
REALIZACIÓN PREFERENTE DE LA INVENCIÓNPREFERRED EMBODIMENT OF THE INVENTION
En una realización preferente, el molde de la invención está configurado en diferentes tamaños de forma hemisférica y tiene una forma y dimensión (preferiblemente con un diámetro entre 10 y 70 mm) adecuada para encajar en el hueco resultante tras la extirpación del tumor sólido. In a preferred embodiment, the mold of the invention is configured in different sizes in a hemispherical shape and has a shape and dimension (preferably with a diameter between 10 and 70 mm) suitable to fit into the hole resulting after removal of the solid tumor.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES202330143U ES1302246Y (en) | 2023-02-01 | 2023-02-01 | hemostatic mold |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES202330143U ES1302246Y (en) | 2023-02-01 | 2023-02-01 | hemostatic mold |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES1302246U true ES1302246U (en) | 2023-07-24 |
| ES1302246Y ES1302246Y (en) | 2023-10-16 |
Family
ID=87281113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES202330143U Active ES1302246Y (en) | 2023-02-01 | 2023-02-01 | hemostatic mold |
Country Status (1)
| Country | Link |
|---|---|
| ES (1) | ES1302246Y (en) |
-
2023
- 2023-02-01 ES ES202330143U patent/ES1302246Y/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES1302246Y (en) | 2023-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2904372T3 (en) | Surgical device for incision and closure | |
| Lee et al. | Initial experience with laparoendoscopic single-site surgery by use of a homemade transumbilical port in urology | |
| Kilty et al. | Extracranial complications of endoscopic transsphenoidal sellar surgery | |
| Nagraj et al. | Early laparoscopic repair for supratrigonal vesicovaginal fistula | |
| 評估使用直徑為 et al. | Needlescopic cholecystectomy: prospective study of 150 patients | |
| Shibao et al. | Laparoendoscopic single-site common bile duct exploration using the manual manipulator | |
| ES1302246U (en) | Hemostatic cast (Machine-translation by Google Translate, not legally binding) | |
| Muzaffar et al. | Randomized comparison of postoperative short-term and mid-term complications between T-tube and primary closure after CBD exploration | |
| Karabicak et al. | Single incision laparoscopic surgery for hepatic hydatid disease Report of a case | |
| Ismaeil et al. | Tie versus clipping typed of cystic duct and artery ligation in laparoscopic cholecystectomy | |
| Lee et al. | Total laparoscopic radical parametrectomy | |
| Kim et al. | Evolution of the Konyang Standard Method for single incision laparoscopic cholecystectomy: the result from a thousand case of a single center experience | |
| RU2713982C2 (en) | Method for surgical removal of acute, subacute and chronic subdural hematomas through milling hole using rigid endoscope with angular direction of optics | |
| Fiddian-Green et al. | Median hepatotomy using ultrasonic dissection for complex hepatobiliary problems | |
| Golab et al. | Simplified laparoscopic technique for the treatment of long distal ureteral stenosis | |
| RU2802674C1 (en) | Method of pole wedge resection of the spleen | |
| RU2750949C1 (en) | Method for treatment of varicocele | |
| Di Bartolomeo et al. | Minilaparoscopic cholecystectomy a one year record. | |
| Thomson et al. | The Open Abdomen: Indications and Management | |
| RU2474389C1 (en) | Method of temporary rib fixation in programmed rethoracotomy and device for implementing it | |
| RU2582456C1 (en) | Method for laparoscopic cholecystectomy in patients receiving treatment by peritoneal dialysis | |
| US20200253603A1 (en) | Apparatus and methods for occlusion of blood vessels | |
| Sangkum et al. | Open-assisted laparoscopic radical cystectomy using an ileal neobladder with intracorporeal urethra-neobladder anastomosis: technique and early experiences | |
| Liu et al. | Transrectal pure NOTES cholecystolithotomy and gallbladder polypectomy with gallbladder preserved: the first report on human cases: 1610 | |
| Modak et al. | 12 Minimally Invasive Approach to Chronic Pancreatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CA1K | Utility model application published |
Ref document number: 1302246 Country of ref document: ES Kind code of ref document: U Effective date: 20230724 |
|
| FG1K | Utility model granted |
Ref document number: 1302246 Country of ref document: ES Kind code of ref document: Y Effective date: 20231009 |